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The death  of  Hagop Akiskal  left  a  great  void  in  all  who
knew  him,  and  many  of  us  knew  him,  indeed,  all  over  the
world.
Hagop was an attentive clinician and innovative researcher
as  well  as  a  mentor  who  accompanied  the  growth  of  many
young  psychiatrists,  a  researcher  sometimes  controversial,
never predictable, whose reflections have changed the way of
seeing and conceiving mental illness in recent decades. And,
above all, a gifted visionary that changed the field of bipolar
disorders  for  better  and  forever.  He  rawarded  of  several
international  prizes,  including  the  Jean  Delay  Prize  of  the
World  Psychiatric  Association  in  2002  (perhaps  the  most
prestigious  award  in  the  field  of  psychiatry).
In our cultures when a great friend dies the village elderly
gather, talk about him and celebrate him or her. Without even
hiding his or her weaknesses. We are old, in our own cultures
of the global village of psychiatry, and we are his/her friends.
We  are  chatting  with  you,  friends  of  the  global  village  of
psychiatry and mental health, chatting about the life of Hagop
Akiskal.
1) First the cultural roots of Hagop.
Globalization in the world of science has led to a system
that  can  be  accessed  from  any  terminal.  If  you  live  in  an
unheard unheard-of  country,  you could write  an editorial  for
NEJM. However, the creation of dominant currents of thought
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often  leads  to  disregarding  the  sometimes-essential  contri-
bution of cultural spheres unknown to those who are leaders at
that  time.  For the researcher,  young or old,  coming from the
periphery of the world, it is not always easy to deal with the top
scientific  centers.  Akiskal  was an exception;  he never,  never
declined to reply to an email sent by a young researcher from
anywhere in the world. Hagop always encouraged the ideas he
thought  were  interesting.  And  he  always  remembered  those
contacts. He kept in touch with them to oversee their research
and how their ideas were evolving. If you look at the list of his
publications, you will be struck with the variety of researchers
he worked with: from the Balkans to Brazil,  from China and
Japan to France, from Australia to Lebanon, and of course with
researchers  from  the  USA,  and  Italy.  In  a  famous  interview
with Paula Clayton in 2008, Akiskal says that he learned a lot
from the Italians, but when you look closely at the names of the
Italians with whom he published most frequently on PubMed,
it turns out that these are two mostly two (at that time) young
psychiatrists  (Perugi  and  Benazzi).  His  generosity  in
responding  to  young  people,  to  the  point  of  being  even
criticized for being too generous as an Editor of an important
Journal,  perhaps had a deep root:  he said once that  he rarely
saw anyone smiling in his family because of the ordeals they
had lived; his reaction was to offer hope.
The cultural roots of Hagop Akiskal, an Armenian whose
family survived the Genocide and adopted Lebanon as the new
country, matured in that melting pot of cultures that Beirut was
during  the  fifties  and  sixties  of  the  last  century.  Hagop  was
drawn  to  journalism  from  an  early  age;  But  that's  his  big-
mother who firmly dissuaded him by specifying that this job
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could expose an Armenian refugee to great risk and, therefore,
urged him to choose a more secure profession, like medicine.
This  inner  fiber  has  always  echoed  in  Hagop's  writings  and
lectures. A true gift of “Sharing” his knowledge.
On the other hand, its origin and roots are fundamental to
understand  his  contribution.  Hagop  spoke  six  languages,
including Turkish, Arabic, and French. He knew the history of
Latin,  Greek,  and  Arab  medicine;  he  was  familiar  with
Kraepelin  and  19th  19th-century  French  psychopathology
which  was  introduced  by  his  early  Lebanese  mentors.  It  is
largely due to his contribution that sources of knowledge were
revived in America, at a time in which the classical European
tradition of psychopathology was largely unknown.
2)  The  second  point  is  the  concepts  of  Spectrum  and
Temperament.  Akiskal  introduced  two  concepts,  at  times
thought  by  some  of  not  being  well  defined,  but  yet  and
unmistakably  proved  to  be  quite  fertile:  The  first  is  the
spectrum  [1,  2].  He  was  convinced  that  (almost)  all  mood
disorders have the same vulnerability matrix and, in agreement
with  Attanasio  Kukopulos,  that  the  primacy  in
psychopathology  is  mania  [3,  4].  This  concept,  an  echo  to
Kraepelin, should have been denied by the DSM-5, a manual
that clearly splits depression from bipolar disorder. Dichotomy
which still represents the source of vivid debate.
The  second  concept  is  that  of  temperament  [1,  5].  The
spectrum has “-under threshold” areas.  Having sub-threshold
characteristics  and/or  temperament,  without  full-blown
disorders,  could  sometimes  be  maladaptive,  or  present
elements of paradoxical adaptivity. Mixing these two aspects
could  simplistically  lead  to  a  vision  of  the  psychiatrist  as  in
“Dr.  Knock  and  the  triumph  of  medicine”  [6]:  if  you
pathologize  the  temperament  heavily  (and  many  are
temperamentally “bipolar”) you will find some idiot who will
think  it  is  appropriate  to  put  lithium  in  the  water  pipes.
However, if we reflect very well on the profound implications
of these concepts, a fundamentally evolutionary vision of the
bipolar  spectrum  emerges  that  can  predict  how  the  alleged
basic vulnerability can also represent a potential advantage in
some situations as in megacities “in which life is expected to
run 24 hours a day for seven days a week” [7], a point one of
us  had  discussed  thoroughly  with  Hagop.  The  presence  of
“dilute”  bipolar  genes  in  the  population  and  the  reason  why
such genes remain in the population,  is  deeply related to the
evolutionary nature of human beings, as exemplified by themes
such as creativity and leadership, extraversion and openness,
which may span across adaptive and functional advantages, to
impairing gradients leading to overt mental illness and social
disadvantages.
From an epidemiological point of view, the hypothesis of
an  adaptive  side  of  hyperactivity  may  explain  how  the
prevalence  of  mood  disorders  in  Western  society  might  be
indeed  elevated  [8,  9]  although  cross-national  differences  in
prevalence  of  mental  disorders  are  far  from  being  settled  as
emerged from the  World  Mental  Health  Survey Initiative  on
which  some  of  us  are  working  for  a  long  time  [10].
Nevertheless,  the  interpretation  of  bipolar  disorders  in  the
evolutionary key, it might be useful to counter the stigmatizing
vision of mood disorders and bipolar disorders in particular.
It  was an important step by Hagop not only to recognize
temperament as the end point of Kraepelin's continuum from
“basic  state”  to  “manic-depressive  insanity”  as  a  historically
significant concept, but also to translate this hypothesis into the
present day and to test it  scientifically. The TEMPS scale he
and his coworkers developed to assess temperament has been
translated  and validated  in  a  vast  number  of  languages  [11  -
18], including studies on the construction of a brief version [19
- 24]. The use of the TEMPS seems particularly important in
the  definition  of  comorbidities  in  the  bipolar  spectrum [25  -
28].
3)  Finally,  the  third  point  concerns  Akiskal's  undisputed
moral  integrity  never  touched  of  the  controversies  that  have
characterized the relationship between, scientific research and
economic  interests.  Some  concepts  introduced  by  Hagop,  as
often  happens  in  innovation,  have  opened  up  a  new  style  of
care and therefore benefits for people but undoubtedly opened
up  market  areas  for  the  pharma  industry.  For  example,  the
dropping  of  the  concept  of  neurotic  depression  and  the
introduction of the diagnosis of Dysthymia. The revolution that
led  to  a  “unitary”  vision  of  depression  came  through  a  long
journey  in  Akiskal's  thought.  In  fact,  a  work  published  in
Science  in  1973  by  a  very  young  Hagop  with  William
McKinney,  entitled  “Depressive  disorders:  toward  a  unified
hypothesis”  [29],  played  a  decisive  role  in  leading  to  the
“unitary”  approach  to  depression  of  the  DSM-III,  notably
different  from  that  of  the  Research  Diagnostic  Criteria.
However, to read that work carefully, his perspective was far
from  a  simplistically  “biological”  view  as  opposed  to  an
equally simplistically “psychogenetic” view of depression. His
was a very coherent perspective to that complex vision of the
mind that was imposing in those years through a new synthesis
that made use of the contributions of the ethological reading of
psychopathology  [30],  of  the  new  cognitive-behavioral
psychology  [31]  and  neurophysiology  [32].
However,  the  loss  of  importance  of  neurotic  depression
was signed by the progressive waning of the relevance of the
context  in  which  mood  symptoms  occur.  This  approach  was
even reinforced in DSM-5, wich, based on field studies [33] no
longer considers bereavement as a criterion for excluding the
diagnosis of depressive episodes [DSM-5 APA 2013]. The new
perspective had relevant consequences on clinical practice: an
observational  study  on  Liaison  Psychiatric  in  US  general
hospitals found from 1988 to 1997 the percentage of diagnosis
of  Major  Depression  with  concomitant  medical  illness
increased  from  6.4%  to  14.7%  while  the  diagnosis  of
Adjustment  Disorder  with  Depressed  Mood  decreased  from
28%  to  14.7%  [34].  It  is  not  difficult  to  observe  that  in  the
same years there was a surge in the market for antidepressants
[35, 36].
In the years immediately following the rise of the concept
of the bipolar spectrum, but not necessarily only due to it, the
market  for  mood  stabilizers  opens  up,  as  well  as  the  newly
synthesized  antipsychotics  which  increasingly  were  assessed
and promoted for their mood-stabilizing properties. Although
Hagop was one of the epigones of this revolution, however, his
figure,  so  outside  the  schemes  of  power,  even so  difficult  to
exploit, cannot be said to have been “used” by those who have
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exploited the economic benefits of the new market. Indeed, his
convictions and his frankness have often not made him a friend
of  the  powerful  world  of  the  pharmaceutical  industry.  This
awareness and pride of the importance of his role as a healer
and researcher “above everything and everyone”;  even when
confronted  with  easy  benefits  made  Hagop’s  legacy  and
memory  even  fonder.
Hagop was an incredible educator and speaker. Whenever
he was giving a speech at a congress, the room was full way
ahead  of  time.  We  all  remembered  rooms  and  corridors
overcrowded with colleagues that would not miss a new Hagop
talk…even if they listened to the “same talk” a month before:
Hagop  was  always  creative  and  always  inspired,  as  any
brilliant free-jazz soloist would, never repeated the same piece.
There  was  always  something  to  be  learned  or  to  discuss
passionately.  He  loved  the  interaction  with  the  public,
especially  with  clinicians.  Particularly  passionate  with  the
younger  ones.  His  deep  clinical  talent  was  obvious  when  he
was presenting data. He did not like the numbers as much as he
liked  the  patients  and  the  clinical  knowledge  to  be  spread
through  his  inspiring  talks,  which  had  a  profound  impact  on
many of us. Large international studies have validated many of
his  theories  [37]  and  his  approach  is  still  under  debate  as
regards the classification of mental disorders [38, 39] and their
management [40].
We  are  so  happy  to  have  had  the  chance  to  work  with
Hagop,  and  to  have  witnessed  his  unique  combination  of
knowledge, reflection and clinical acumen being coupled with
courage  and  ethics  over  the  years.  Hagop  you  are  deeply
missed and as you can tell, our connections and conversations
will continue beyond the limits of time.
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(reprint fist edition 1925).
Carta MG, Preti A, Akiskal HS. Coping with the new Era: Noise and[7]
light  pollution,  hperactivity  and  steroid  hormones.  towards  an
evolutionary  view  of  bipolar  disorders.  Clin  Pract  Epidemiol  Ment
Health 2018; 14: 33-6.
[http://dx.doi.org/10.2174/1745017901814010033] [PMID: 29541149]
Compton WM, Conway KP,  Stinson FS,  Grant  BF.  Changes  in  the[8]
prevalence of major depression and comorbid substance use disorders
in  the  United  States  between  1991-1992  and  2001-2002.  Am  J
Psychiatry  2006;  163(12):  2141-7.
[http://dx.doi.org/10.1176/ajp.2006.163.12.2141] [PMID: 17151166]
Goldney RD, Eckert KA, Hawthorne G, Taylor AW. Changes in the[9]
prevalence of major depression in an Australian community sample
between 1998 and 2008. Aust N Z J Psychiatry 2010; 44(10): 901-10.
[http://dx.doi.org/10.3109/00048674.2010.490520] [PMID: 20932204]
Demyttenaere  K,  Bruffaerts  R,  Posada-Villa  J,  et  al.  WHO  World[10]
Mental  Health Survey Consortium. Prevalence,  severity,  and unmet
need  for  treatment  of  mental  disorders  in  the  World  Health
Organization  World  Mental  Health  Surveys.  JAMA 2004;  291(21):
2581-90.
[http://dx.doi.org/10.1001/jama.291.21.2581] [PMID: 15173149]
Fountoulakis KN, Siamouli M, Magiria M, et al. Standardization of[11]
the TEMPS-A in the Greek general population. J Affect Disord 2014;
158: 19-29.
[http://dx.doi.org/10.1016/j.jad.2013.12.030] [PMID: 24655761]
Figueira ML, Caeiro L, Ferro A, et al. Validation of the Temperament[12]
Evaluation  of  Memphis,  Pisa,  Paris  and  San  Diego  (TEMPS-A):
Portuguese-Lisbon version. J Affect Disord 2008; 111(2-3): 193-203.
[http://dx.doi.org/10.1016/j.jad.2008.03.001] [PMID: 18440648]
Pompili  M,  Girardi  P,  Tatarelli  R,  et  al.  TEMPS-A  (Rome):[13]
psychometric validation of affective temperaments in clinically well
subjects  in  mid-  and  south  Italy.  J  Affect  Disord  2008;  107(1-3):
63-75.
[http://dx.doi.org/10.1016/j.jad.2007.07.031] [PMID: 17884175]
Vázquez GH, Nasetta S, Mercado B, et al. Validation of the TEMPS-[14]
A  Buenos  Aires:  Spanish  psychometric  validation  of  affective
temperaments  in  a  population  study  of  Argentina.  J  Affect  Disord
2007; 100(1-3): 23-9.
[http://dx.doi.org/10.1016/j.jad.2006.11.028] [PMID: 17306377]
Karam  EG,  Mneimneh  Z,  Salamoun  M,  Akiskal  KK,  Akiskal  HS.[15]
Psychometric  properties  of  the  Lebanese-Arabic  TEMPS-A:  A
national epidemiologic study. J Affect Disord 2005; 87(2-3): 169-83.
[http://dx.doi.org/10.1016/j.jad.2005.02.010] [PMID: 16023731]
Karam EG, Mneimneh ZN, Salamoun MM, Akiskal HS, Akiskal KK.[16]
Suitability  of  the  TEMPS-A  for  population-based  studies:  Ease  of
administration and stability of affective temperaments in its Lebanese
version. J Affect Disord 2007; 98(1-2): 45-53.
[http://dx.doi.org/10.1016/j.jad.2006.06.029] [PMID: 16949160]
Sánchez-Moreno  J,  Barrantes-Vidal  N,  Vieta  E,  et  al.  Process  of[17]
adaptation to  Spanish of  the  Temperament  Evaluation of  Memphis,
Pisa,  Paris  and  San  Diego  Scale.  Self  applied  version  (TEMPS-A).
Actas Esp Psiquiatr 2005; 33(5): 325-30.
[PMID: 16155815]
Akiskal  HS,  Akiskal  K,  Allilaire  JF,  et  al.  Validating  affective[18]
temperaments  in  their  subaffective  and  socially  positive  attributes:
Psychometric, clinical and familial data from a French national study.
J Affect Disord 2005; 85(1-2): 29-36.
[http://dx.doi.org/10.1016/j.jad.2003.12.009] [PMID: 15780673]
Erfurth A, Gerlach AL, Hellweg I, Boenigk I, Michael N, Akiskal HS.[19]
Studies  on  a  German  (Münster)  version  of  the  temperament  auto-
questionnaire  TEMPS-A:  Construction  and  validation  of  the
briefTEMPS-M.  J  Affect  Disord  2005;  85(1-2):  53-69.  a
[http://dx.doi.org/10.1016/S0165-0327(03)00102-2]  [PMID:
15780676]
Erfurth  A,  Gerlach  AL,  Michael  N,  et  al.  Distribution  and  gender[20]
effects  of  the  subscales  of  a  German  version  of  the  temperament
autoquestionnaire briefTEMPS-M in a university student population. J
Affect Disord 2005; 85(1-2): 71-6. b
[http://dx.doi.org/10.1016/j.jad.2003.07.003] [PMID: 15780677]
Preti A, Corrias I, Gabbrielli M, et al. The independence of schizotypy[21]
from affective temperaments--a combined confirmatory factor analysis
of  SPQ  and  the  short  TEMPS-A.  Psychiatry  Res  2015;  225(1-2):
145-56.
[http://dx.doi.org/10.1016/j.psychres.2014.10.027] [PMID: 25467700]
Preti A, Vellante M, Gabbrielli M, et al. Confirmatory factor analysis[22]
and  measurement  invariance  by  gender,  age  and  levels  of
psychological distress of the short TEMPS-A. J Affect Disord 2013;
151(3): 995-1002.
[http://dx.doi.org/10.1016/j.jad.2013.08.025] [PMID: 24054919]
Preti A, Vellante M, Zucca G, Tondo L, Akiskal K, Akiskal H. The[23]
Italian  version  of  the  validated  short  TEMPS-A:  The  temperament
evaluation of  Memphis,  Pisa,  Paris  and San Diego.  J  Affect  Disord
2010; 120(1-3): 207-12.
[http://dx.doi.org/10.1016/j.jad.2009.02.025] [PMID: 19327844]
Woodruff E, Genaro LT, Landeira-Fernandez J, et al. Validation of the[24]
Brazilian  brief  version  of  the  temperament  auto-questionnaire
In Memory of Hagop Akiskal Clinical Practice & Epidemiology in Mental Health, 2021, Volume 17   51
TEMPS-A: The brief TEMPS-Rio de Janeiro. J Affect Disord 2011;
134(1-3): 65-76.
[http://dx.doi.org/10.1016/j.jad.2011.02.005] [PMID: 21782248]
Vyssoki B, Blüml V, Gleiss A, et al. The impact of temperament in the[25]
course of alcohol dependence. J Affect Disord 2011; 135(1-3): 177-83.
[http://dx.doi.org/10.1016/j.jad.2011.07.007] [PMID: 21840604]
Salem  BA,  Vyssoki  B,  Lesch  OM,  Erfurth  A.  Lesch  typology  and[26]
temperament in opioid dependence: a cross-sectional study. J Affect
Disord 2014; 165: 203-7.
[http://dx.doi.org/10.1016/j.jad.2014.04.066] [PMID: 24882201]
Schiele  MA,  Herzog  K,  Kollert  L,  et  al.  Affective  temperaments[27]
(TEMPS-A)  in  panic  disorder  and  healthy  probands:  Genetic




Skala  K,  Kapusta  ND,  Schlaff  G,  et  al.  Suicidal  ideation  and[28]
temperament:  An  investigation  among  college  students.  J  Affect
Disord 2012; 141(2-3): 399-405.
[http://dx.doi.org/10.1016/j.jad.2012.03.010] [PMID: 22475473]
Akiskal HS, McKinney WT Jr. Depressive disorders: Toward a unified[29]
hypothesis. Science 1973; 182(4107): 20-9.
[http://dx.doi.org/10.1126/science.182.4107.20] [PMID: 4199732]
McKinney  WT.  Biobehaviorial  models  of  depression  in[30]
monkeys.Animal models in psychiatry. Oxford: Pergamon 1977; pp.
117-26.
Beck  A.  Depression:  Causes  andTreatment.  Philadelphia:  Univ.  of[31]
Pennsylvania Press 1967.
Eclles JC. The understanding of the Brain. New York: McGraw-Hill[32]
1973.
Karam EG, Tabet CC, Alam D, et al. Bereavement related and non-[33]
bereavement related depressions: A comparative field study. J Affect
Disord 2009; 112(1-3): 102-10.
[http://dx.doi.org/10.1016/j.jad.2008.03.016] [PMID: 18514321]
Diefenbacher A, Strain JJ.  Consultation-liaison psychiatry: Stability[34]
and  change  over  a  10-year  period.  Gen  Hosp  Psychiatry  2002;  24:
249-56.
Carta MG, Kovess V, Hardoy MC, et al. Psychosocial wellbeing and[35]
psychiatric  care  in  the  European  Communities:  Analysis  of  macro
indicators. Soc Psychiatry Psychiatr Epidemiol 2004; 39(11): 883-92.
[http://dx.doi.org/10.1007/s00127-004-0871-0] [PMID: 15549240]
Carta  MG, Angermeyer  MC. The triumph of  the  DSM and patient-[36]
centered psychiatry. Cult Med Psychiatry 2015; 39(1): 200-3.
[http://dx.doi.org/10.1007/s11013-014-9411-x] [PMID: 25324034]
Angst J, Gamma A, Neuenschwander M, et al. Prevalence of mental[37]
disorders in the Zurich Cohort Study: A twenty year prospective study.
Epidemiol Psichiatr Soc 2005; 14(2): 68-76.
[http://dx.doi.org/10.1017/S1121189X00006278] [PMID: 16001703]
Vieta E. DSM-5.1. Acta Psychiatr Scand 2016; 134(3): 187-8.[38]
[http://dx.doi.org/10.1111/acps.12624] [PMID: 27500779]
Kessing LV, González-Pinto A, Fagiolini A, et al. DSM-5 and ICD-11[39]
criteria for bipolar disorder: Implications for the prevalence of bipolar
disorder and validity of the diagnosis - A narrative review from the
ECNP bipolar disorders network. Eur Neuropsychopharmacol 2021;
1:S0924-977X(21): 00113-9.
[http://dx.doi.org/10.1016/j.euroneuro.2021.01.097]
Pacchiarotti  I,  Bond  DJ,  Baldessarini  RJ,  et  al.  The  International[40]
Society  for  Bipolar  Disorders  (ISBD)  task  force  report  on




© 2021 Carta et al.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is
available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
